Pretreatment with vaginal misoprostol before vacuum aspiratio

Completed

• Conditions: Induced abortion; Pregnancy and Childbirth; Abortion

• Registration Number: ISRCTN85366519
• Lead Sponsor: DP/UNFPA/WHO/World Bank - Special Programme of Research, Development and Research Training in Human Reproduction

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2004-04-01
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 4464

Inclusion Criteria

1. Pregnancy of less than 12 completed weeks
2. Be informed about the study and sign a consent form
3. Agree to return for a follow-up visit five to ten days after surgery

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Will evaluate if preoperative treatment with 0.4 mg misoprostol administered vaginally three hours before vacuum aspiration can reduce complications of surgical first trimester abortion.

Secondary Outcome Measures

Name	Time	Method
o secondary outcome measures